Business Wire

PA-THEOREM-CLINICAL

Del
Theorem Clinical Research Expands Leadership and Prepares for Growth with Addition of Kathryn Bohannon and Angela Weston

Theorem Clinical Research , a leading contract research organization that optimizes trial conduct, has named Kathryn Bohannon as vice president of biopharmaceutical development and Angela Weston as vice president of business development in Europe and Asia.

Bohannon increases Theorem’s scientific and medical leadership in pediatrics and rare disease with almost 20 years of diverse pharmaceutical research and development experience, including Phase I-IV clinical research, laboratory research and development as well as U.S. and global project management and direct sales and marketing. She has developed and managed projects across multiple therapeutic areas and clinical settings, including the Best Pharmaceuticals for Children Act – Data Coordinating Center within the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Weston brings more than 20 years of experience to Theorem, spanning a broad range of commercial disciplines in the pharmaceutical, biotech and medical device industries. She has worked extensively in business development, previously serving as senior vice president for business development at a global clinical contract research organization. In this role, she organized and managed the pharmaceutical, medical device and clinical resource sales teams. Additionally, Weston is a clinical nurse specialist and paramedic.

“These professionals further enhance our capabilities and client services,” said John Potthoff , Theorem president and CEO. “We have the right experts in place to provide meaningful expertise in key aspects of clinical trials.”

Learn more about Theorem, its services and therapeutic areas of expertise at www.theoremclinical.com .

About Theorem Clinical Research

Theorem Clinical Research is a global provider of comprehensive clinical services with staff throughout the Americas, Europe and Asia and a client base comprised of the world’s leading biopharmaceutical and medical device companies. With industry-leading experts, unparalleled therapeutic expertise and innovative technology, Theorem is focused on analytic-based development, combination trials and personal data applications to simplify complex trials.

Contact:

SCORR Marketing
Lea Studer, +1-308-237-5567
lea@scorrmarketing.com

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Andersen Global styrker platformen i Filippinerne med Du-Baladad and Associates3.5.2025 00:55:00 CEST | Pressemeddelelse

Andersen Global forstærker sit engagement i Asien og Stillehavsområdet gennem en samarbejdsaftale med Du-Baladad and Associates, et skatte- og virksomhedsservicefirma med base i Filippinerne. Firmaet blev grundlagt i 2009 af administrerende partner Benedicta Du-Baladad og tilbyder en bred vifte af ydelser, herunder skatterådgivning og -planlægning, transfer pricing, international skat, skattetvister og -retssager, compliance og bistand i forbindelse med incitamenter. Du-Baladad and Associates anerkendes konsekvent som et førende skattefirma i Filippinerne af Chambers and Partners, International Tax Review, The Legal 500 og Asialaw og servicerer multinationale virksomheder og store indenlandske selskaber på tværs af brancher, herunder inden for finansielle tjenesteydelser, energi, olie og gas, produktion, fast ejendom og teknologi. "Vores firma bygger på en helhedsorienteret tilgang til kunderne, som prioriterer praktiske og skræddersyede strategier til at styre risici og understøtte vo

Spatial Releases 2025 1.0.1 with Enhancements for CAD Translation, Model Simplification, and Mesh Preparation for Manufacturing and Simulation2.5.2025 16:47:00 CEST | Press release

Spatial Corp., the leading software development toolkit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, announces the 2025 1.0.1 release and updates across several product lines, reaffirming its commitment to providing innovative solutions for its customers in domains ranging from CAD to simulation, manufacturing, and beyond. The 2025 1.0.1 release delivers expanded functionality designed to streamline manufacturing and simulation workflows. Key highlights include a new custom feature detection API in ACIS for more efficient model simplification, expanded CAD format support—including STEP AP242 PMI writing—and continued enhancements to hidden-body removal. With this release, Spatial reduces manual tasks, increases fidelity in geometry translation, and strengthens its toolset for automated design-to-manufacture and design-to-simulation pipelines. 3D ACIS ModelerCustom Feature Detection (Beta): Model simplification often requires manual

Decent Cybersecurity Joins the Council of Slovak Exporters to Strengthen European Cybersecurity Exports2.5.2025 15:51:00 CEST | Press release

Decent Cybersecurity, a leading European provider of post-quantum security solutions, announces its membership in the Council of Slovak Exporters (CSE), reinforcing its commitment to expanding advanced cybersecurity exports across global markets. This strategic partnership combines Decent Cybersecurity's expertise in critical infrastructure protection with CSE's established export promotion platform. As a company holding national, EU, and NATO "Secret" level security clearances, Decent Cybersecurity brings specialized knowledge in post-quantum security, blockchain technology, and space traffic management solutions to the Council's network. "Joining the Council of Slovak Exporters represents a significant opportunity to strengthen Slovakia's position in the global cybersecurity market," said Matej Michalko, Founder and CEO of Decent Cybersecurity and a long-term expert on post-quantum cryptography and blockchain. "As cyber threats continue to evolve, our advanced solutions are increasin

Saudi Arabia Hosts EDGEx 2025, Pushing the Boundaries of Education2.5.2025 15:29:00 CEST | Press release

Saudi Arabia has taken another step forward in its educational reform journey with the successful conclusion of the International Education Exhibition (EDGEx), held from April 13–16, 2025. Organized by the Ministry of Education, the event convened education leaders, technology developers, and policymakers from around the world under the theme “Beyond Readiness.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250502190798/en/ Saudi Arabia Hosts EDGEx 2025, Pushing the Boundaries of Education (Photo: AETOSWire) Over four days, EDGEx welcomed more than 20,000 local and international visitors, including government representatives, senior educators, academics, business leaders, and professionals in the field. The exhibition served as a platform for dialogue, knowledge exchange, and cross-sector collaboration—bringing together institutions, companies, and decision-makers to explore how education and training can evolve in a rapidl

IFF Announces Tender Offers for Certain Outstanding Series of Notes2.5.2025 15:10:00 CEST | Press release

IFF (NYSE: IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, the “Notes”) for an aggregate purchase price, excluding accrued and unpaid interest, of up to $1.8 billion. Pool 1 Tender Offers Pool 1 Maximum Amount: $1.0 billion(1(a)) Title of Security CUSIP/ISIN Principal Amount Outstanding(in millions) Acceptance Priority Level(2) Series Tender Cap(3) U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread(4) Early Tender Payment (4)(5) 1.230% Senior Notes due 2025 459506AN1 U45950AE9 $1,000 1 $500 million 5.000% UST due 9/30/25 FIT3 + 0 bps $30 1.832% Senior Notes due 2027 459506AP6 U45950AF6 $1,200 2 $300 million 3.750% UST due 4/30/27 FIT1 + 75 bps $30 2.300% Senior Notes due 2030 459506AQ4 U45950AG4 $1,500 3 N/A 3.875% UST due 4/30/30 FIT1 + 110 bps $30 4.450% Senior Notes due 2028 459506AK7 US459506AK78 $400 4 N/A 3.750% UST due 4/15/28 FIT1 + 95 bps $30 Poo

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye